---
$id: https://graph.org.ai/products/commodity/51111863
$type: Product
source: UNSPSC
code: "51111863"
title: "Octreotide"
class: "51111800"
classTitle: "Hormones and antihormones"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Octreotide

**UNSPSC Code**: 51111863
**Class**: [Hormones and antihormones](Hormones and antihormones.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a somatostatin receptor agonist with the molecular formula C49H66N10O10S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier RWM8CCW8GP, chemically known as l-cysteinamide, d-phenylalanyl-l-cysteinyl-l-phenylalanyl-d-tryptophyl-l-lysyl-l-threonyl-n-(2-hydroxy-1-(hydroxymethyl)propyl)-, cyclic (2->7)-disulfide, (r-(r*,r*))- but generally known as octreotide, which bears US NIH Compound Identifier 383414. European Medicines Agency schedules Octreotide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09417MIG. The term OCTREOTIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 39, No. 5, 1985, List 25). World Health Organization schedules octreotide in its Anatomical Therapeutic Chemical (ATC) Classification. OCTREOTIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule octreotide under HS 29371900 and SITC 54154. As of Q4 2014, OCTREOTIDE remains the US FDA Preferred Term for this commodity. Octreotide bears US NLM identifiers UMLS ID C0028833 and NCI Concept Code C711. SMILES: S1SCC(NC(=O)C(N)CC2CCCCC2)C(=O)NC(C(=O)NC(CC2C3C([NH]C2)CCCC3)C(=O)NC(CCCCN)C(=O)NC(C(O)C)C(=O)NC(C1)C(=O)NC(C(O)C)CO)CC1CCCCC1.

